Skip to main content
Carelabs Co.,Ltd logo

Carelabs Co.,Ltd — Investor Relations & Filings

Ticker · 263700 ISIN · KR7263700007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 455 across all filing types
Latest filing 2021-06-04 Major Shareholding Noti…
Country KR South Korea
Listing KO 263700

About Carelabs Co.,Ltd

https://www.carelabs.co.kr/

Carelabs Co., Ltd. is a platform company that provides comprehensive IT services for the healthcare and beauty care sectors. The company develops and operates solutions aimed at creating a more convenient and accessible healthcare ecosystem by resolving imbalances in medical information. Its core services include specialized customer relationship management (CRM) software for hospitals, such as 'SmartCRM' and 'UnoCRM', which support patient management and marketing activities. Additionally, Carelabs offers performance-based digital marketing services tailored to clients in the medical field. Through its technology-driven platforms, the company facilitates online-to-offline (O2O) connections within the health and beauty markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (CityLabs Co., Ltd.) and special related parties in Carelabs Co., Ltd. This document type is specifically used for reporting significant changes in shareholding thresholds, which falls under the 'Major Shareholding Notification' category.
2021-06-04 Korean
[기재정정]합병등종료보고서(분할)
M&A Activity Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a 'Report on the Completion of Merger/Split' (합병등종료보고서). It explicitly details corrections made to financial tables (specifically the summary financial information before and after the split) that were originally submitted on May 4, 2021. Since this is a regulatory filing regarding corporate restructuring (split/merger) and does not fit into the specific categories of M&A activity (which usually refers to the initial proposal/takeover bid) or other specialized categories, it is classified as a Regulatory Filing (RNS).
2021-05-31 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Carelabs) regarding a 'Correction Report' (정정신고) for a 'Stock Collateral Provision Agreement' (주식 담보제공 계약). This type of filing is a standard regulatory disclosure in the Korean market (DART system) concerning changes in share pledges by the major shareholder. Since it does not fit into specific categories like M&A, Earnings, or Dividends, and is a formal regulatory announcement of a corporate event, it is classified as a Regulatory Filing (RNS).
2021-05-31 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a '합병등종료보고서' (Report on the Completion of Merger, etc.), which in the context of Korean regulatory filings (DART) refers to the finalization of a previously announced asset acquisition or merger transaction. The document details the completion of a real estate asset acquisition (land and building) by Carelabs, confirming the final payment date and the resulting impact on the company's financial statements. Since this relates to a specific corporate transaction (asset acquisition/M&A activity) and is not a general regulatory announcement or a report publication notice, it falls under the M&A Activity category.
2021-05-25 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 케어랩스' covering the period from January 1, 2021, to March 31, 2021. It contains detailed corporate information, financial data, and management disclosures typical of a quarterly filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange. It is not an announcement or a certification, but the report itself. Q1 2021
2021-05-14 Korean
합병등종료보고서(분할)
M&A Activity Classification · 100% confidence The document is a '합병등종료보고서' (Report on Completion of Merger/Split), which is a formal regulatory filing in South Korea submitted to the Financial Supervisory Service (FSS). It details the completion of a corporate split (division) process, including the timeline, financial impact, and balance sheet adjustments. Since this is a specific regulatory filing regarding corporate restructuring (M&A/Split) and does not fit into the other categories like 10-K or ER, it is classified as a Regulatory Filing (RNS).
2021-05-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.